External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
NCT: NCT06788977 · RECRUITING
Brief Summary
This online registry aims to understand the potential benefits and safety of external trigeminal nerve stimulation for the treatment of migraine in pregnant women. Women do not need to use external trigeminal nerve stimulation or any other form of migraine treatment to participate in the registry. The main question it aims to answer is: Is external trigeminal nerve stimulation a safe and effective option for migraine treatment during and after pregnancy? There are no required changes in migraine treatment to participate in this registry. Participants may or may not use external trigeminal nerve stimulation or any other treatment they currently use and may still participate in the registry. There are no clinic or research visits, as the registry is entirely online. Participants will be asked to complete up to six 15- 20-minute surveys over a time period of up to 12 months.
Frequently Asked Questions
What is External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy?
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy is a clinical trial registered under NCT06788977. Current status: RECRUITING.
What is the status of NCT06788977?
The current status of NCT06788977 (External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy) is: RECRUITING.
When did External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy start?
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy started on 2024-11-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.